Sernova Biotherapeutics (TSX:SVA) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:SVA Sernova Biotherapeutics Inc TSX:SVA
28 GF Score
Price C$0.11
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics FFO?

FFO (Funds from operations) only applies to REITs.

TSX:SVA
28GF Score
Sernova Biotherapeutics Inc TSX:SVA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Business Description

Other Exchanges SEOVF:USAPSH0:Germany
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
28GF Score

Get the complete analysis for TSX:SVA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.11
Price